S&P 100

S&P 100 handeln
3.600,12 PKT -9,05 PKT -0,25 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0AE1W

ISIN US78380F1021


Analysen zu S&P 100-Werten

Datum Rating Analyst
01.07.11 Bank of America equal-weight Barclays Capital
01.07.11 Medtronic overweight Barclays Capital
01.07.11 Citigroup neutral Credit Suisse Group
30.06.11 Bank of America outperform RBC Capital Markets
30.06.11 eBay equal-weight Barclays Capital
30.06.11 Exelon neutral UBS AG
30.06.11 Bank of America neutral UBS AG
30.06.11 Gilead Sciences overweight Piper Jaffray & Co.
30.06.11 Bank of America halten Independent Research GmbH
30.06.11 Eli Lilly hold Citigroup Corp.
30.06.11 Nike buy Citigroup Corp.
30.06.11 Medtronic buy Citigroup Corp.
30.06.11 Bank of America neutral Nomura
30.06.11 Bank of America buy Citigroup Corp.
30.06.11 Apple overweight Barclays Capital
30.06.11 Nike overweight Barclays Capital
30.06.11 Apple outperform RBC Capital Markets
30.06.11 Coca-Cola buy Citigroup Corp.
30.06.11 Oracle buy UBS AG
05.07.11 Microsoft overweight Morgan Stanley
29.06.11 Apple outperform Sanford C. Bernstein and Co., Inc.
04.07.11 Citigroup buy Banc of America Securities-Merrill Lynch
29.06.11 Bank of America neutral UBS AG
29.06.11 Nike buy UBS AG
29.06.11 Bank of America halten Independent Research GmbH
29.06.11 Accenture buy Citigroup Corp.
29.06.11 ExxonMobil buy Citigroup Corp.
29.06.11 Linde outperform Macquarie Research
29.06.11 Amazon overweight Morgan Stanley
29.06.11 Walt Disney overweight Barclays Capital
29.06.11 Microsoft buy Banc of America Securities-Merrill Lynch
29.06.11 Nike overweight Barclays Capital
29.06.11 Visa buy Jefferies & Company Inc.
29.06.11 MasterCard buy Jefferies & Company Inc.
29.06.11 Microsoft overweight Morgan Stanley
28.06.11 Medtronic buy Citigroup Corp.
28.06.11 Walt Disney buy Nomura
28.06.11 Oracle halten Hamburger Sparkasse AG (Haspa)
01.07.11 Microsoft overweight JP Morgan Chase & Co.
28.06.11 Accenture overweight Barclays Capital